These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709 [TBL] [Abstract][Full Text] [Related]
30. Images in cardiovascular medicine. Torsade de pointes in a patient with Wolff-Parkinson-White syndrome. Kobza R; Kottkamp H; Hindricks G Circulation; 2005 Apr; 111(13):e173-4. PubMed ID: 15811862 [No Abstract] [Full Text] [Related]
31. Blocking effect of verapamil on conduction over a catecholamine-sensitive bypass tract in exercise-induced Wolff-Parkinson-White syndrome. Horio Y; Matsuyama K; Morikami Y; Rokutanda M; Hirata A; Okumura K; Takaoka K; Uchida H; Kugiyama K; Araki S J Am Coll Cardiol; 1984 Jul; 4(1):186-91. PubMed ID: 6736448 [TBL] [Abstract][Full Text] [Related]
32. Effects of epinephrine in local dental anesthesia in patients with coronary artery disease. Neves RS; Neves IL; Giorgi DM; Grupi CJ; César LA; Hueb W; Grinberg M Arq Bras Cardiol; 2007 May; 88(5):545-51. PubMed ID: 17589629 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. Calkins H; Sousa J; el-Atassi R; Rosenheck S; de Buitleir M; Kou WH; Kadish AH; Langberg JJ; Morady F N Engl J Med; 1991 Jun; 324(23):1612-8. PubMed ID: 2030717 [TBL] [Abstract][Full Text] [Related]
34. CARDIAC ARRHYTHMIAS IN DENTISTRY. KAUFMAN L Lancet; 1965 Aug; 2(7406):287. PubMed ID: 14330077 [No Abstract] [Full Text] [Related]
35. [Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks]. Negro R; Aloisi B; Russo L; Mazzaglia G; Liistro M; Brancati B Clin Ter; 1981 May; 97(3):291-7. PubMed ID: 6116557 [No Abstract] [Full Text] [Related]
36. [Anesthetic management using propofol and fentanyl of a patient with concealed Wolff-Parkinson-White syndrome]. Yamaguchi S; Nagao M; Mishio M; Okuda Y; Kitajima T Masui; 1998 Jun; 47(6):730-3. PubMed ID: 9691594 [TBL] [Abstract][Full Text] [Related]
38. Effects of new beta-blocking agent (DL-tiprenolol) on conduction within normal and anomalous atrioventricular pathways in Wolff-Parkinson-White syndrome. Roelandt J; Schamroth L; Hugenholtz PG Br Heart J; 1972 Dec; 34(12):1272-82. PubMed ID: 4405234 [No Abstract] [Full Text] [Related]
39. Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study Group. Darpö B; Edvardsson N J Cardiovasc Pharmacol; 1995 Aug; 26(2):198-206. PubMed ID: 7475043 [TBL] [Abstract][Full Text] [Related]
40. Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome. Spurrell RA; Krikler DM; Sowton E Br Heart J; 1974 Mar; 36(3):256-64. PubMed ID: 4824534 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]